NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaOriginal Research · 1991 · 3,564 citations
2. 2Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1Prognostic Study · 2011 · 1,634 citations
3. 3Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumorspreclinical · 2008 · 51 citations
4. 4Cancer‐germline gene expression in pediatric solid tumors using quantitative real‐time PCROriginal Research · 2006 · 69 citations